2017 annual financial data
Redhill Biopharma 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,117.27%.
Operating income was -51,972,000 USD and net income was -45,544,000 USD.
Operating cash flow was -44,769,000 USD.
Get free Redhill Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,007,000 USD
- Operating income
- -51,972,000 USD
- Net income
- -45,544,000 USD
- Operating cash flow
- -44,769,000 USD